Lincoln National Corp’s Novartis NVS Stock Holding History

Lincoln National Corp’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,302	Closed	-$997K	–	781
2024 Q1	$997K	Sell	10,302 -524	-5%	-$53.7K	0.02%	520
2023 Q4	$1.09M	Buy	10,826 +1,846	+21%	+$178K	0.02%	438
2023 Q3	$915K	Buy	8,980 +196	+2%	+$19.9K	0.02%	428
2023 Q2	$886K	Buy	8,784 +689	+9%	+$68.9K	0.02%	447
2023 Q1	$745K	Sell	8,095 -40	-0.5%	-$3.49K	0.02%	464
2022 Q4	$738K	Buy	8,135 +1,193	+17%	+$100K	0.02%	430
2022 Q3	$528K	Buy	6,942 +231	+3%	+$19.1K	0.01%	478
2022 Q2	$568K	Buy	6,711 +1,094	+19%	+$96K	0.01%	463
2022 Q1	$493K	Sell	5,617 -327	-6%	-$28.3K	0.01%	526
2021 Q4	$520K	Sell	5,944 -17	-0.3%	-$1.41K	0.01%	512
2021 Q3	$488K	Sell	5,961 -1,704	-22%	-$153K	0.01%	508
2021 Q2	$699K	Buy	7,665 +725	+10%	+$64.6K	0.02%	399
2021 Q1	$593K	Buy	6,940 +229	+3%	+$20.6K	0.01%	416
2020 Q4	$634K	Sell	6,711 -160	-2%	-$14K	0.02%	378
2020 Q3	$597K	Sell	6,871 -1,460	-18%	-$126K	0.02%	347
2020 Q2	$727K	Buy	8,331 +75	+0.9%	+$6.47K	0.02%	303
2020 Q1	$681K	Sell	8,256 -537	-6%	-$47.9K	0.03%	278
2019 Q4	$832K	Buy	8,793 +4,173	+90%	+$374K	0.03%	295
2019 Q3	$401K	Buy	4,620 +2,170	+89%	+$195K	0.01%	393
2019 Q2	$224K	Sell	2,450 -337	-12%	-$28.5K	0.01%	504
2019 Q1	$240K	Sell	2,787 -185	-6%	-$14.9K	0.01%	444
2018 Q4	$228K	Buy	2,972 +106	+4%	+$8.25K	0.01%	413
2018 Q3	$221K	Sell	2,866 -176	-6%	-$13K	0.01%	430
2018 Q2	$206K	Sell	3,042 -992	-25%	-$68.5K	0.01%	451
2018 Q1	$292K	Sell	4,034 -4,070	-50%	-$310K	0.01%	376
2017 Q4	$610K	Buy	8,104 +4,305	+113%	+$325K	0.02%	327
2017 Q3	$292K	Buy	3,799 +405	+12%	+$30.6K	0.01%	326
2017 Q2	$253K	Buy	+3,394	New	+$241K	0.01%	297
2017 Q1	–	Sell	-28,141	Closed	-$1.84M	–	353
2016 Q4	$1.84M	Buy	28,141 +1,409	+5%	+$91.4K	0.1%	85
2016 Q3	$1.89M	Buy	26,732 +775	+3%	+$56.5K	0.11%	76
2016 Q2	$1.92M	Sell	25,957 -2,212	-8%	-$153K	0.11%	73
2016 Q1	$1.83M	Buy	28,169 +2,668	+10%	+$182K	0.13%	66
2015 Q4	$1.86M	Buy	25,501 +1,182	+5%	+$93.9K	0.15%	53
2015 Q3	$2.03M	Buy	24,319 +627	+3%	+$55.8K	0.16%	46
2015 Q2	$2.25M	Buy	23,692 +476	+2%	+$43.7K	0.17%	39
2015 Q1	$2.05M	Buy	23,216 +1,332	+6%	+$118K	0.17%	41
2014 Q4	$1.82M	Buy	21,884 +468	+2%	+$38.8K	0.16%	46
2014 Q3	$1.81M	Buy	21,416 +1,540	+8%	+$125K	0.17%	42
2014 Q2	$1.61M	Buy	19,876 +105	+0.5%	+$8.26K	0.17%	42
2014 Q1	$1.51M	Buy	19,771 +1,023	+5%	+$74.5K	0.21%	39
2013 Q4	$1.35M	Buy	+18,748	New	+$1.3M	0.2%	39

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCM

Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

Lincoln National Corp's NVS Position: Q2 2024 in Review

Lincoln National Corp sold out of Novartis (NVS) in Q2 2024, closing a stake of 10,302 shares — an estimated $997K sold.

Lincoln National Corp first reported a position in NVS in Q4 2013 and held it in 41 quarters. The position peaked at $2.25M in Q2 2015. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

Lincoln National Corp reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
Lincoln National Corp sold 10,302 Novartis shares in Q2 2024, an estimated $997K.
Lincoln National Corp first reported a position in Novartis in Q4 2013 and held it in 41 quarters.
Lincoln National Corp's Novartis position peaked at $2.25M in Q2 2015.
1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.